@article{sabatier:inserm-01985845, TITLE = {{Safety Results and Analysis of Eribulin Efficacy according to Previous Microtubules-Inhibitors Sensitivity in the French Prospective Expanded Access Program for Heavily Pre-treated Metastatic Breast Cancer}}, AUTHOR = {Sabatier, Renaud and Di{\'e}ras, V{\'e}ronique and Pivot, Xavier B. and Brain, Etienne and Roche, Henri and Extra, Jean-Marc and Monneur, Audrey and Provansal, Magali and Tarpin, Carole and Bertucci, Fran{\c c}ois and Viens, Patrice and Zemmour, Christophe and Gon{\c c}alves, Anthony}, URL = {https://inserm.hal.science/inserm-01985845}, JOURNAL = {{Breast Cancer Research and Treatment}}, PUBLISHER = {{Springer Verlag}}, VOLUME = {50}, NUMBER = {4}, PAGES = {1226-1237}, YEAR = {2018}, MONTH = Oct, DOI = {10.4143/crt.2017.446}, KEYWORDS = {Metastatic breast cancer ; Eribulin ; Safety ; Survival ; Microtubule inhibition}, PDF = {https://inserm.hal.science/inserm-01985845/file/crt-2017-446.pdf}, HAL_ID = {inserm-01985845}, HAL_VERSION = {v1}, }